Decreased expression of peroxisome proliferator-activated receptor alpha indicates unfavorable outcomes in hepatocellular carcinoma

References

• FornerAReigMBruixJHepatocellular carcinomaLancet20183911301131429307467
   PubMed Web of Science ®Google Scholar
• CaiSHLuSXLiuLLZhangCZYunJPIncreased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinomaTherap Adv Gastroenterol201710761771
   PubMed Web of Science ®Google Scholar
• ChenSLLiuLLLuSXHBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasisMol Oncol2017111225124028580773
   PubMed Web of Science ®Google Scholar
• VanderHMCantleyLCThompsonCBUnderstanding the Warburg effect: the metabolic requirements of cell proliferationScience20093241029103319460998
   PubMed Web of Science ®Google Scholar
• NiemanKMKennyHAPenickaCVAdipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growthNat Med2011171498150322037646
   PubMed Web of Science ®Google Scholar
• HirayamaAKamiKSugimotoMQuantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometryCancer Res2009694918492519458066
   PubMed Web of Science ®Google Scholar
• WangMDWuHFuGBAcetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patientsHepatology2016631272128626698170
   PubMed Web of Science ®Google Scholar
• ChungSKimYJYangSJLeeYLeeMNutrigenomic functions of PPARs in obesogenic environmentsPPAR Res20162016479457628042289
   PubMed Web of Science ®Google Scholar
• MelloTMaterozziMGalliAPPARs and mitochondrial metabolism: from NAFLD to HCCPPAR Res20162016740323028115925
   PubMed Web of Science ®Google Scholar
• YoussefJBadrMPeroxisome proliferator-activated receptors and cancer: challenges and opportunitiesBr J Pharmacol2011164688221449912
   PubMed Web of Science ®Google Scholar
• SuchanekKMMayFJRobinsonJAPeroxisome proliferator-activated receptor alpha in the human breast cancer cell lines MCF-7 and MDA-MB-231Mol Carcinog20023416517112203367
   PubMed Web of Science ®Google Scholar
• AbuAOWetterstenHIWeissRHInhibition of PPARα induces cell cycle arrest and apoptosis, and synergizes with glycolysis inhibition in kidney cancer cellsPLoS One20138e7111523951092
   PubMed Web of Science ®Google Scholar
• PetersJMCattleyRCGonzalezFJRole of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643Carcinogenesis199718202920339395198
   PubMed Web of Science ®Google Scholar
• CaiSCaoJYuTXiaMPengJEffectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pretreated with interferon compared with de novo therapy with entecavir and telbivudineMedicine (Baltimore)201796e702128562554
   PubMed Web of Science ®Google Scholar
• CaiSYuTJiangYZhangYLvFPengJComparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week resultClin Exp Med20161642943626164128
   PubMed Web of Science ®Google Scholar
• CaiSHLvFFZhangYHJiangYGPengJDynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHBBMC Infect Dis2014148524528480
   PubMed Web of Science ®Google Scholar
• OuHCaiSLiuYXiaMPengJA noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis BTherap Adv Gastroenterol201710207217
   PubMed Web of Science ®Google Scholar
• ShaohangCZejinODuanLRisk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndromeUnited Eur Gastroenterol J20186558566
   PubMed Web of Science ®Google Scholar
• PavlovaNNThompsonCBThe emerging hallmarks of cancer metabolismCell Metab201623274726771115
   PubMed Web of Science ®Google Scholar
• SunamiYRebeloAKleeffJLipid metabolism and lipid droplets in pancreatic cancer and stellate cellsCancers (Basel)201710E329295482
   PubMed Web of Science ®Google Scholar
• LiZKangYLipid metabolism fuels cancer’s spreadCell Metab20172522823028178563
   PubMed Web of Science ®Google Scholar
• HanLShenWJBittnerSKraemerFBAzharSPPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-alphaFuture Cardiol20171325927828581332
   PubMedGoogle Scholar
• GaoJYuanSJinJShiJHouYPPARα regulates tumor progression, foe or friend?Eur J Pharmacol201576556056426409040
   PubMed Web of Science ®Google Scholar
• HuangJYBiYZuoGWFengTEffects of HBx on localization of PPARγ in HepG2 cell lineActa Academiae Medicinae Militaris Tertiae20081816931696
   Google Scholar
• MoranEPMaJXTherapeutic effects of PPAR alpha on neuronal death and microvascular impairmentPPAR Res2015201559542625705219
   PubMed Web of Science ®Google Scholar
• LeeJWBajwaPJCarsonMJFenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient miceGastroenterology200713310812317631136
   PubMed Web of Science ®Google Scholar
• BakerBGBallGRRakhaEALack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancerBreast Cancer Res Treat201313712713723208589
   PubMed Web of Science ®Google Scholar
• ZhouJZhangSXueJActivation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cellsJ Biol Chem2012287351613516922932900
   PubMed Web of Science ®Google Scholar
• WejkszaKLee-ChangCBodogaiMCancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor alphaJ Immunol20131902575258423408836
   PubMed Web of Science ®Google Scholar
• ChangNWWuCTChenDRYehCYLinCHigh levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferationJ Nutr Biochem20132427428122902323
   PubMed Web of Science ®Google Scholar
• ScaleraATarantinoGCould metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?World J Gastroenterol2014209217922825071314
   PubMed Web of Science ®Google Scholar
• YamasakiDKawabeNNakamuraHFenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanismsEur J Cell Biol20119065766421514001
   PubMed Web of Science ®Google Scholar
• TanakaNMoriyaKKiyosawaKKoikeKGonzalezFJAoyamaTPPARα activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in miceJ Clin Invest200811868369418188449
   PubMed Web of Science ®Google Scholar
• AdeghateEAdemAHasanMYTekesKKalaszHMedicinal chemistry and actions of dual and pan PPAR modulatorsOpen Med Chem J20115939821966330
   PubMedGoogle Scholar
• MartinassoGOraldiMTrombettaAInvolvement of PPARs in cell proliferation and apoptosis in human colon cancer specimens and in normal and cancer cell linesPPAR Res200720079341617389773
   PubMed Web of Science ®Google Scholar
• WagnerCEJurutkaPWMarshallPAHeckMCRetinoid X receptor selective agonists and their synthetic methodsCurr Top Med Chem20171774276727320333
   PubMed Web of Science ®Google Scholar
• TripathySChapmanJDHanCYAll-trans-retinoic acid enhances mitochondrial function in models of human liverMol Pharmacol20168956057426921399
   PubMed Web of Science ®Google Scholar
• MarkMGhyselinckNBChambonPFunction of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesisAnnu Rev Pharmacol Toxicol20064645148016402912
   PubMed Web of Science ®Google Scholar
• ChambonPA decade of molecular biology of retinoic acid receptorsFASEB J1996109409548801176
   PubMed Web of Science ®Google Scholar
• HoshikawaYKankiKAshlaAAc-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cellsCancer Sci201110293494121272161
   PubMed Web of Science ®Google Scholar
• Matsushima-NishiwakiRShidojiYNishiwakiSYamadaTMoriwakiHMutoYAberrant metabolism of retinoid X receptor proteins in human hepatocellular carcinomaMol Cell Endocrinol19961211791908892319
   PubMed Web of Science ®Google Scholar
• YoshimuraKMutoYShimizuMPhosphorylated retinoid X receptor alpha loses its heterodimeric activity with retinoic acid receptor betaCancer Sci2007981868187417900311
   PubMed Web of Science ®Google Scholar
• MooreDMKalvakolanuDVLippmanSMRetinoic acid and interferon in human cancer: mechanistic and clinical studiesSemin Hematol1994313137
   PubMed Web of Science ®Google Scholar
• LippmanSMLotanRAdvances in the development of retinoids as chemopreventive agentsJ Nutr2000130479S482S10721933
   PubMed Web of Science ®Google Scholar
• SunSYLotanRRetinoids and their receptors in cancer development and chemopreventionCrit Rev Oncol Hematol200241415511796231
   PubMed Web of Science ®Google Scholar